These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 36211267)
1. CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis. Deng H; Zhang J; Zheng Y; Li J; Xiao Q; Wei F; Han W; Xu X; Zhang Y Front Surg; 2022; 9():878648. PubMed ID: 36211267 [TBL] [Abstract][Full Text] [Related]
2. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633 [TBL] [Abstract][Full Text] [Related]
3. Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma. Liu T; Li ZZ; Sun L; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P BMC Cancer; 2023 Oct; 23(1):1007. PubMed ID: 37858061 [TBL] [Abstract][Full Text] [Related]
4. Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma. Shang BB; Chen J; Wang ZG; Liu H PeerJ; 2021; 9():e12315. PubMed ID: 34754620 [TBL] [Abstract][Full Text] [Related]
5. Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma. Ma J; Jin J; Lu H; Zhang J; Li Y; Cai X Front Mol Biosci; 2022; 9():889414. PubMed ID: 35769911 [No Abstract] [Full Text] [Related]
6. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer. Deng H; Li T; Wei F; Han W; Xu X; Zhang Y Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965 [No Abstract] [Full Text] [Related]
7. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Li L; Wang X; Ding Y; Hui N; Su B; Yang M Eur J Med Res; 2022 Oct; 27(1):216. PubMed ID: 36307879 [TBL] [Abstract][Full Text] [Related]
8. Coiled-coil domain-containing protein 58 (CCDC58) is a novel prognostic biomarker correlated with mitochondrial functions in hepatocellular carcinoma. Chen L; Zhang J; Yang Y; Shu J; Zheng J; Zhan X; Guo M Am J Transl Res; 2023; 15(4):2568-2584. PubMed ID: 37193151 [TBL] [Abstract][Full Text] [Related]
9. Prognostic and Immunological Significance of FUNDC1 in Hepatocellular Carcinoma: A Study on TCGA Mining. Le Y; Kong H; Gao X; Zhu J Comput Math Methods Med; 2022; 2022():8371885. PubMed ID: 36017155 [TBL] [Abstract][Full Text] [Related]
10. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma. Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X Front Immunol; 2022; 13():1076045. PubMed ID: 36591279 [TBL] [Abstract][Full Text] [Related]
11. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma. Ma C; Kang W; Yu L; Yang Z; Ding T Front Oncol; 2020; 10():590006. PubMed ID: 33363020 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis and validation of SNX7 as a novel biomarker for the diagnosis, prognosis, and prediction of chemotherapy and immunotherapy response in hepatocellular carcinoma. Chen J; Gao G; Zhang Y; Dai P; Huang Y BMC Cancer; 2023 Sep; 23(1):899. PubMed ID: 37743471 [TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma. Li R; Zhao W; Liang R; Jin C; Xiong H Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972 [No Abstract] [Full Text] [Related]
14. High Level of Serum Coiled-coil Domain Containing 25 (CCDC25) as a Diagnostic Marker for Cholangiocarcinoma But Not for Other Cancers. Jannawan A; Silsirivanit A; Seubwai W; Wongwattanakul M; Proungvitaya T; Aung TM; Roytrakul S; Chiawiriyabunya I; Proungvitaya S In Vivo; 2023; 37(1):294-303. PubMed ID: 36593058 [TBL] [Abstract][Full Text] [Related]
15. SLC17A2 Expression Correlates with Prognosis and Immune Infiltrates in Hepatocellular Carcinoma. Wang Z; Chen X; Jiang Z Comb Chem High Throughput Screen; 2022; 25(12):2001-2015. PubMed ID: 35081886 [TBL] [Abstract][Full Text] [Related]
16. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma. Feng NN; Du XY; Zhang YS; Jiao ZK; Wu XH; Yang BM Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595 [TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis. Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R Front Genet; 2022; 13():907331. PubMed ID: 35938001 [No Abstract] [Full Text] [Related]
18. Coiled-Coil Domain-Containing Protein 45 Is a Potential Prognostic Biomarker and Is Associated with Immune Cell Enrichment of Hepatocellular Carcinoma. Liu S; Jia L; Quan B; Rong G; Li M; Xie R; Cai Y; Bi Y; Han S Dis Markers; 2022; 2022():7745315. PubMed ID: 36618966 [TBL] [Abstract][Full Text] [Related]
19. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma. Li D; Chen B; Zeng Y; Wang H Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of Yang P; Liu H; Li Y; Gao Q; Chen X; Chang J; Li Y; Chen S; Dong R; Wu H; Liu C; Liu G Front Genet; 2022; 13():959832. PubMed ID: 36299588 [No Abstract] [Full Text] [Related] [Next] [New Search]